Top Markets
#1 Pleasing Gold Pleasing Gold +1,501.14%
#2 PulseChain PulseChain +54.75%
#3 Ontology Gas Ontology Gas +34.63%
#4 Merlin's Seal BTC Merlin's Seal BTC +33.38%
#5 BOOK OF MEME BOOK OF MEME +29.72%
#6 ConstitutionDAO ConstitutionDAO +25.40%
#7 Collect on Fanable Collect on Fanable +24.53%
#8 Unit Pump Unit Pump +24.29%
#9 Pump.fun Pump.fun +24.29%
#10 Neiro Neiro +23.35%
Coin of the day
Pleasing Gold Pleasing Gold
Settings
Language
ENGLISH
Currency
USD
Theme
Molecure S.A. Molecure S.A.

Molecure S.A.

MOC
Rank in Stocks #26168
Operating as a biopharmaceutical firm in Poland, Molecure S.A. specializes in... Operating as a biopharmaceutical firm in Poland, Molecure S.A. specializes in the research, development, and commercialization of innovative therapies designed to combat neoplastic (cancer) and inflammatory conditions. The company's pipeline prominently features OATD-01, a chitotriosidase/acidic mammalian chitinase inhibitor that has successfully advanced through Phase I clinical trials for the treatment of idiopathic pulmonary fibrosis and sarcoidosis. Additionally, Molecure is progressing its YKL-40 program for cancer and fibrosis, OATD-02 for oncology applications, and a Deubiquitinase program. Established in 2012, this Warsaw-headquartered enterprise adopted the name Molecure S.A. in March 2022, having previously been known as OncoArendi Therapeutics S.A.
Share Price
$1.73
Market Cap
$42.88M
Change (1 day)
2.16%
Change (1 year)
-18.85%
Country
PL
Trade Molecure S.A. (MOC)

Category

Healthcare
Number of shares outstanding for Molecure S.A. (MOC)
Number of shares outstanding as of August 2026: 0
According to Molecure S.A. latest financial reports and stock price the company's current number of shares outstanding is 0. At the end of August 2026 the company had 0 shares outstanding. The number of outstanding shares is usually impacted by stock plits and shares buy back.
Shares outstanding history for Molecure S.A. (MOC) from 2026 to 2026
Shares Outstanding at the end of each year
Year Shares Outstanding Change
Not enough data for the provided dates.
Shares Outstanding for similar companies or competitors
Company Shares Outstanding Difference Country
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 253.90M -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 62.19M -
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
 483.58M -
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 396.00M -
US